QTTB · ISSUER CIK 1661998
Q32 Bio Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Q32 Bio Inc. insiders reported $0.00 of open-market purchases and $320K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 6 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$320KInsider selling
−$320KNet open-market
Oct 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 202617:30 | Oct 6, 2026 | QTTB | CEO, Director | S · SellLate 8d | $8.32 | −3,221 | 340,038 | -1% | −$27K | ||
| Oct 14, 202617:30 | Oct 6, 2026 | QTTB | Chief Scientific Officer | S · SellLate 8d | $8.32 | −917 | 126,854 | -1% | −$8K | ||
| Oct 14, 202617:30 | Oct 6, 2026 | QTTB | CFO and President | S · SellLate 8d | $8.32 | −1,301 | 137,170 | -1% | −$11K | ||
| Aug 27, 202616:10 | Aug 25, 2026 | QTTB | CEO, Director | S · Sell | $16.56 | −9,845 | 343,259 | -3% | −$163K | ||
| Aug 27, 202616:10 | Aug 25, 2026 | QTTB | CFO and President | S · Sell | $16.56 | −3,972 | 138,471 | -3% | −$66K | ||
| Aug 27, 202616:10 | Aug 25, 2026 | QTTB | Chief Scientific Officer | S · Sell | $16.56 | −2,798 | 127,771 | -2% | −$46K |